The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol

被引：0
|
作者：
Kapitza, Christoph
Flint, Anne
Hindsberger, Charlotte
Zdravkovic, Milan
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A593 / A593
页数：1
相关论文
共 50 条
  • [11] Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist
    Bode, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (02): : S59 - S70
  • [12] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
    Flint, A.
    Kapitza, C.
    Hindsberger, C.
    Zdravkovic, M.
    DIABETOLOGIA, 2008, 51 : S354 - S354
  • [13] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
    Flint, Anne
    Kapitza, Christoph
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A165 - A165
  • [14] Safety, tolerability, pharmacokineties and pharmacodynamics of the once-daily GLP-1 analogue liraglutide in healthy Japanese subjects
    Irie, Shin
    Matsumura, Yoriko
    Zdravkovic, Milan
    Jacobsen, Lisbeth V.
    Kageyama, Shigeru
    DIABETES, 2007, 56 : A540 - A540
  • [15] Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
    Jacobsen, Lisbeth V.
    Hindsberger, Charlotte
    Robson, Richard
    Zdravkovic, Milan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (06) : 898 - 905
  • [16] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
  • [17] Erratum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
    A Astrup
    R Carraro
    N Finer
    A Harper
    M Kunesova
    M E J Lean
    L Niskanen
    M F Rasmussen
    A Rissanen
    S Rössner
    M J Savolainen
    L Van Gaal
    International Journal of Obesity, 2012, 36 : 890 - 890
  • [18] Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
    Horowitz, Michael
    Flint, Anne
    Jones, Karen L.
    Hindsberger, Charlotte
    Rasmussen, Mads F.
    Kapitza, Christoph
    Doran, Selena
    Jax, Thomas
    Zdravkovic, Milan
    Chapman, Ian M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (02) : 258 - 266
  • [19] Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
    Flint, Anne
    Nazzal, Khalil
    Jagielski, Pawel
    Hindsberger, Charlotte
    Zdravkovic, Milan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) : 807 - 814
  • [20] Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes
    Seino, Y.
    Rasmussen, M. F.
    Nishida, T.
    Kaku, K.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1013 - 1022
12345